• SENSEX
    NIFTY 50
Business

Eris Lifesciences acquires anti-diabetes drug Zomelis from Novartis for $13 million

Updated : December 04, 2019 11:20 AM IST

Eris Lifesciences acquired the trademark for anti-diabetes drug Zomelis from Novartis AG for a consideration of $13 million.
The company will start selling the drug in the Indian market from December 10 onwards.

You May Also Like

Live TV
Advertisement